Health
Study elucidates the mode of action of SGLT2 inhibitors in diabetes – News-Medical.Net
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown.
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown. In a study conducted by a research group led by Peter Wolf, Martin Krssak and Michael Krebs from MedUni Vienna’s Department of Medicine III, magnetic resonance spectroscopy (MRS) was used to show that there is a direct correlation between the elimination of glucose via the kidneys and new glucose production in the liver.
A single dose of the SGLT-2 inhibitor dapagliflozin gives rise…
-
Noosa News23 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News22 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News21 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
General19 hours agoDairy farmers devastated by floods across parts of New South Wales